Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypersensitivity Reaction
  Free Subscription

Articles published in
J Dermatol
    June 2026
  1. SAITO R, Sasaki W, Watanabe H, Hashimoto M, et al
    Extended-Interval Dosing and Discontinuation of Dupilumab in Atopic Dermatitis: A Real-World Retrospective Study.
    J Dermatol. 2026 Jun 11. doi: 10.1111/1346-8138.70350.
    >> Share

  2. TSUNEMI Y, Igarashi A, Ishido T, Saeki H, et al
    Real-World Maintenance of Remission in Atopic Dermatitis Patients With Upadacitinib: A Multicenter Retrospective Study in Japan (ROADMAP Study).
    J Dermatol. 2026 Jun 4. doi: 10.1111/1346-8138.70299.
    >> Share

    May 2026
  3. KAWASAKI-NAGANO M, Tamagawa-Mineoka R, Masuda K, Katoh N, et al
    Preoperative Questionnaire Evaluation and Testing for Latex Allergy: A Retrospective Study From 2015 to 2021.
    J Dermatol. 2026 May 28. doi: 10.1111/1346-8138.70333.
    >> Share

  4. NAKAHARA T, Kaneko S, Katoh N, Ozawa M, et al
    Prevalence, Severity, and Clinical Course of Atopic Dermatitis in Japan: A Web-Based Questionnaire Survey.
    J Dermatol. 2026 May 25. doi: 10.1111/1346-8138.70329.
    >> Share

  5. SUN LD, Behl A, Danilov PN, Agiri FY, et al
    Healthcare Resource Utilization and Use of Biologics in Chronic Spontaneous Urticaria.
    J Dermatol. 2026;53:832-836.
    >> Share

    April 2026
  6. TSUJI G, Fuyuno Y, Kawamura K, Yumine A, et al
    Tapinarof as a Therapeutic Aryl Hydrocarbon Receptor-Modulating Agent in the Treatment of Atopic Dermatitis.
    J Dermatol. 2026 Apr 29. doi: 10.1111/1346-8138.70295.
    >> Share

  7. AOKI A, Fukamatsu H, Yamamoto T, Aoyama Y, et al
    Sunflower Seed-Induced Anaphylaxis With Immunoglobulin E Reactivity to 2S Albumins and Novel 60 kDa Antigen Identified by Immunoblot Analysis.
    J Dermatol. 2026 Apr 10. doi: 10.1111/1346-8138.70266.
    >> Share

    March 2026
  8. YAMADA Y, Yoshihara S
    Serum TARC Levels Reflect the Severity and Prognosis of Atopic Dermatitis in Infants Under 6 Months of Age: A Retrospective Study in a Pediatric Primary Care Practice.
    J Dermatol. 2026 Mar 30. doi: 10.1111/1346-8138.70245.
    >> Share

  9. CONDE G, Carmenate Y, Bello G, Armstrong AW, et al
    Concordance Between Patient- and Physician-Reported Improvement With Dupilumab in Atopic Dermatitis.
    J Dermatol. 2026 Mar 13. doi: 10.1111/1346-8138.70202.
    >> Share

  10. NUMATA T, Nishikawa T, Suzuki R, Ito T, et al
    Intravenous Tranexamic Acid-Induced Anaphylaxis.
    J Dermatol. 2026 Mar 9. doi: 10.1111/1346-8138.70219.
    >> Share

  11. BASTOS T, Ito M, Kamata M, Shimizu T, et al
    A 308-nm Excimer Lamp Ameliorates MC903-Induced Atopic Dermatitis With Reductions of Intraepidermal Nerve Fiber Density and Expression of Thymic Stromal Lymphopoietin.
    J Dermatol. 2026 Mar 7. doi: 10.1111/1346-8138.70209.
    >> Share

    February 2026
  12. TAKEDA K, Takeuchi M, Hashizume H, Kuriyama N, et al
    Cardiovascular Risk in Psoriasis Compared With Atopic Dermatitis: The Shizuoka Kokuho Database.
    J Dermatol. 2026 Feb 25. doi: 10.1111/1346-8138.70197.
    >> Share

  13. OKAMOTO H, Nakamura Y
    Dysbiosis in the Pathogenesis of Atopic Dermatitis.
    J Dermatol. 2026 Feb 20. doi: 10.1111/1346-8138.70191.
    >> Share

  14. YONEYAMA M, Hagino T, Uchiyama A, Saeki H, et al
    Seventy-Two-Week Real-World Outcomes of Tralokinumab Treatment for Moderate-To-Severe Atopic Dermatitis: Analyses Stratified by Baseline Rash and Itch Severity.
    J Dermatol. 2026 Feb 16. doi: 10.1111/1346-8138.70187.
    >> Share

  15. SHIBA M, Hagino T, Uchiyama A, Saeki H, et al
    Effectiveness of Anti-IL-13 Antibodies on Head and Neck Lesions in Atopic Dermatitis: 48-Week Outcomes by Lebrikizumab and Tralokinumab.
    J Dermatol. 2026 Feb 11. doi: 10.1111/1346-8138.70183.
    >> Share

  16. KATOH N
    The Pathogenesis of Atopic Dermatitis-Trends for the Future.
    J Dermatol. 2026 Feb 3. doi: 10.1111/1346-8138.70164.
    >> Share

    January 2026
  17. ONISHI S, Yasutomi Y, Tsedendorj O, Morizane S, et al
    Cytokine Milieu Relevant to Atopic Dermatitis Enhances Epidermal Trypsin-Like Serine Protease Activity, Which Is Pharmacologically Suppressed in Human Keratinocytes.
    J Dermatol. 2026 Jan 27. doi: 10.1111/1346-8138.70160.
    >> Share

  18. OKADA-JOKAKU M, Ohara Y, Kido C, Watanabe K, et al
    Effectiveness of Combinational Therapy With Tapinarof and Narrowband Ultraviolet B for Atopic Dermatitis.
    J Dermatol. 2026 Jan 27. doi: 10.1111/1346-8138.70158.
    >> Share

  19. MATSUMOTO S, Watanabe H, Saito R, Moriwaki M, et al
    A Case of Multiple Recalcitrant Verruca Vulgaris Associated With Atopic Dermatitis Successfully Treated With Nemolizumab and Topical Imiquimod.
    J Dermatol. 2026 Jan 18. doi: 10.1111/1346-8138.70145.
    >> Share

  20. FUTAMURA M, Kang Y, Singh A, Danjo J, et al
    Treatment Patterns and Healthcare Utilization on Pediatric Atopic Dermatitis With Allergic Comorbidities: A Japanese Claims-Based Study.
    J Dermatol. 2026 Jan 8. doi: 10.1111/1346-8138.70102.
    >> Share

  21. SHIBA M, Hagino T, Uchiyama A, Saeki H, et al
    Long-Term, Site-Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72-Week Real-World Study.
    J Dermatol. 2026 Jan 5. doi: 10.1111/1346-8138.70138.
    >> Share

  22. OTERO-FERNANDEZ MN, Munoz-Bellido FJ, Laffond-Yges E, Lazaro-Sastre M, et al
    Minocycline-Induced Delayed Dermographism With Tolerance to Doxycycline.
    J Dermatol. 2026;53:145-148.
    >> Share

  23. SAITO R, Furutani K, Mihara S, Numata T, et al
    Disease Duration of Urticaria: A Sub-Analysis of a Survey on Subtypes and Clinical Characteristics of 1061 Patients With Urticaria in the Primary Care Institutes in Japan.
    J Dermatol. 2026;53:131-134.
    >> Share

    December 2025
  24. HAYAKAWA T, Komai T, Yotsuyanagi T, Shimizu T, et al
    Anaphylaxis to Total Parenteral Nutrition Components Diagnosed by Skin Tests.
    J Dermatol. 2025 Dec 27. doi: 10.1111/1346-8138.70127.
    >> Share

  25. SUGIURA A, Morimoto H, Yamada S, Honda T, et al
    Anaphylaxis and Episodic Urticaria Associated With Sialodochitis Fibrinosa.
    J Dermatol. 2025 Dec 21. doi: 10.1111/1346-8138.70120.
    >> Share

  26. FAN X, Liu R, Cao X, Zhang Z, et al
    The Predictive Value of Inflammatory Markers in the Severity and Mortality Risk of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    J Dermatol. 2025 Dec 19. doi: 10.1111/1346-8138.70116.
    >> Share

  27. KATO H, Tamagawa-Mineoka R, Nakatani E, Yoshimura K, et al
    Safety Evaluation of Fine Bubble Shower Washing for Patients With Atopic Dermatitis: A Double-Blind, Randomized, Prospective Crossover Clinical Trial.
    J Dermatol. 2025 Dec 17. doi: 10.1111/1346-8138.70117.
    >> Share

  28. SAKAI T
    Stratum Corneum Ceramide Abnormalities in Atopic Dermatitis: Pathophysiology and Implications for Disease Management.
    J Dermatol. 2025 Dec 15. doi: 10.1111/1346-8138.70098.
    >> Share

  29. IINO K, Takamura S, Fukuda T
    Perinatal Management and Clinical Outcomes of Hereditary Angioedema in Japan: A Case Series and Comprehensive Literature Review.
    J Dermatol. 2025;52:1881-1887.
    >> Share

  30. FUKUNAGA A, Kishi Y, Sunaga Y, Arima K, et al
    Prevalence, Comorbidities, and Current Management of Chronic Spontaneous Urticaria in Japan: Retrospective Claims Database Study.
    J Dermatol. 2025;52:1775-1787.
    >> Share

    November 2025
  31. KOIKE Y, Morisaki H, Motooka D, Matsumoto M, et al
    Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab or Cyclosporine A: A Descriptive Case Series.
    J Dermatol. 2025 Nov 28. doi: 10.1111/1346-8138.70083.
    >> Share

  32. TOYOSHIMA R, Aso S, Matsui H, Fushimi K, et al
    Comparative Impact of NSAIDs Versus Acetaminophen on Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Cohort Study of 2484 Patients From a Nationwide Inpatient Database.
    J Dermatol. 2025 Nov 26. doi: 10.1111/1346-8138.70082.
    >> Share

  33. YAMAMOTO-HANADA K, Kawada Y, Okamoto K, Matsukawa M, et al
    Barriers to Accurate Diagnosis of Infantile Atopic Dermatitis: Insights From a Survey of Pediatricians.
    J Dermatol. 2025 Nov 14. doi: 10.1111/1346-8138.70052.
    >> Share

  34. HASHIMOTO M, Hayakawa R, Fukuyama M, Ohyama M, et al
    Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report.
    J Dermatol. 2025 Nov 11. doi: 10.1111/1346-8138.70051.
    >> Share

    October 2025
  35. HEERFORDT IM, Middelboe M, Haerskjold A, Horwitz A, et al
    Toxic Epidermal Necrolysis and Mortality: A Danish Cohort Study With 30 Years of Follow-Up.
    J Dermatol. 2025 Oct 27. doi: 10.1111/1346-8138.70040.
    >> Share

  36. SOU M, Hagihara E, Itou A, Koshikawa S, et al
    A Case of Anaphylaxis due to Carmine Added as a Colorant to Thai Tea.
    J Dermatol. 2025 Oct 23. doi: 10.1111/1346-8138.70034.
    >> Share

  37. HAMAMURA Y, Niimura T, Matsumoto K, Kambara T, et al
    Cotrimoxazole-Induced Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms With Persistent Human Herpesvirus-6 DNA Detection and Flare Without Elevated TARC Levels.
    J Dermatol. 2025 Oct 23. doi: 10.1111/1346-8138.70028.
    >> Share

  38. WATANABE A, Kamata M, Okada Y, Suzuki S, et al
    Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70026.
    >> Share

  39. PENG G, Abudouwanli A, Sun Q, Tan Y, et al
    Role of Antimicrobial Peptides in the Pathogenesis of Atopic Dermatitis.
    J Dermatol. 2025 Oct 8. doi: 10.1111/1346-8138.17975.
    >> Share

    September 2025
  40. DEKIO I, Katsuta M, Ishiuji Y, Nobeyama Y, et al
    Discontinuation Reasons and Drug Survival of Dupilumab in Real-World Adult Atopic Dermatitis Patients in Three Healthcare Facilities in Tokyo and Yokohama (2018-2023).
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17927.
    >> Share

    August 2025
  41. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis.
    J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17915.
    >> Share

  42. MATSUO M, Takagi H, Iwata H
    A Case of Atopic Dermatitis Accompanied by Prurigo Nodularis Developed Eosinophilic Pneumonia on Dupilumab Therapy.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17892.
    >> Share

    July 2025
  43. SASAKI W, Saito R, Suzuki K, Watanabe D, et al
    Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Jul 23. doi: 10.1111/1346-8138.17877.
    >> Share

  44. TAKAMURA S, Sugai S, Fukuda T
    Long-Term Clinical Courses and Stratified Management of Dupilumab-Associated Inflammatory Arthritis in Atopic Dermatitis: Two Japanese Cases With Over 200 Weeks of Follow-Up and Musculoskeletal Ultrasound Assessment.
    J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17873.
    >> Share

  45. KIMURA H, Oginezawa M, Hama N, Watanabe Y, et al
    Efficacy and Safety of Etanercept in Japanese Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Unresponsive to Systemic Steroid Therapy: A Multicenter, Open-Label, Single-Arm Study.
    J Dermatol. 2025 Jul 14. doi: 10.1111/1346-8138.17860.
    >> Share

  46. CHEN HC, Chen YC, Chuang MH, Chien WC, et al
    Increased Risk of Chronic Kidney Disease in Atopic Dermatitis: A Nationwide, Population-Based Cohort Analysis.
    J Dermatol. 2025 Jul 10. doi: 10.1111/1346-8138.17841.
    >> Share

    June 2025
  47. YUNOKI M, Kondo S, Otsuka M, Tokura Y, et al
    A Case of Anaphylaxis to Persulfate Salts Contained in Hair Bleaching Powder, Showing Exclusive Immediate-Type but not Delayed-Type Allergy.
    J Dermatol. 2025 Jun 27. doi: 10.1111/1346-8138.17837.
    >> Share

  48. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment for Atopic Dermatitis-Induced Rash on the Face and Neck: Efficacy at Reducing Local Side Effects of Topical Steroid and Tacrolimus Ointment.
    J Dermatol. 2025 Jun 26. doi: 10.1111/1346-8138.17817.
    >> Share

  49. KAWAKAMI D, Hagihara E, Hata T, Hasegawa J, et al
    Coconut Anaphylaxis Induced by Occupational Sensitization to Cosmetics via the Skin in a Spa Therapist.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17820.
    >> Share

  50. TONE Y, Matsui M, Park A, Otani S, et al
    A Case of Stevens-Johnson Syndrome Induced by Selpercatinib.
    J Dermatol. 2025;52:1066-1069.
    >> Share

  51. SUEKI H, Sugiyama S, Aoyama Y, Yamamoto T, et al
    Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.
    J Dermatol. 2025;52:1015-1030.
    >> Share

    May 2025
  52. AKAI N, Hashimoto T, Okuno S, Takai S, et al
    Apalutamide-Induced Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms Involving Reactivation of Human Herpesvirus-6 and Cytomegalovirus: A Case Report.
    J Dermatol. 2025 May 19. doi: 10.1111/1346-8138.17787.
    >> Share

  53. LI C, Dai M, Gu Q, Lu K, et al
    Incidence of the Stevens-Johnson syndrome spectrum and its patterns in urban China.
    J Dermatol. 2025;52:897-906.
    >> Share

  54. TANEMURA A, Ma Y, Sakaki-Yumoto M, Hiro S, et al
    Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database.
    J Dermatol. 2025;52:831-840.
    >> Share

    April 2025
  55. SHEN MH, An HY, Shih CL
    Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor Analysis.
    J Dermatol. 2025 Apr 12. doi: 10.1111/1346-8138.17738.
    >> Share

  56. YAMAMURA S, Myangat TM, Sawamura S, Shimada S, et al
    Serum circulating S100A7 and S100A15 DNA copies are elevated in patients with psoriasis and atopic dermatitis.
    J Dermatol. 2025 Apr 1. doi: 10.1111/1346-8138.17727.
    >> Share

    March 2025
  57. CHO YT, Chou HI, Chan TC, Chen YC, et al
    Disease burden and treatment preference for moderate-to-severe atopic dermatitis in Taiwan: A discrete-choice experiment.
    J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17721.
    >> Share

  58. MORI Y, Okamoto-Kawai N, Inuo C, Matsumoto S, et al
    Usefulness of gibberellin-regulated protein specific IgE measurement in patients with systemic symptoms of apple allergy with exercise.
    J Dermatol. 2025 Mar 12. doi: 10.1111/1346-8138.17691.
    >> Share

  59. TAKEUCHI S, Zeze N, Imayama S, Nakahara T, et al
    Case of allergic contact dermatitis caused by polyurethane elastic cannula.
    J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17687.
    >> Share

  60. KUBO A
    History and prospects of Nagashima-type palmoplantar keratosis, the most common palmoplantar keratoderma in east Asian populations.
    J Dermatol. 2025;52:408-415.
    >> Share

  61. KIM MH
    Epidemiological insights into chronic urticaria, vitiligo, alopecia areata, and herpes zoster following COVID-19 infection: A nationwide population-based study.
    J Dermatol. 2025;52:499-504.
    >> Share

    February 2025
  62. HAMASAKI M, Sakai T, Hatano Y
    Cochineal allergy confirmed by specific IgE testing: Review of diagnostic sensitivity.
    J Dermatol. 2025 Feb 20. doi: 10.1111/1346-8138.17674.
    >> Share

  63. KAWAMOTO M, Sakai T, Uchimura K, Shono T, et al
    Anaphylaxis triggered by dog contact and exhaustion in a dog-allergic patient with atopic dermatitis.
    J Dermatol. 2025 Feb 17. doi: 10.1111/1346-8138.17676.
    >> Share

  64. VAN BUCHEM-POST NF, Ouwerkerk W, Stalman EW, van Dam KPJ, et al
    Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
    J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17664.
    >> Share

  65. MA Y, Chachin M, Hirose T, Nakamura K, et al
    Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database.
    J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17643.
    >> Share

  66. MIZUKAWA Y, Hama N, Niihara H, Miyagawa F, et al
    Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
    J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17609.
    >> Share

  67. YAMAMOTO T
    Erythroderma in the elderly.
    J Dermatol. 2025;52:221-227.
    >> Share

  68. MORIOKE S, Moriwaki M, Tanaka A, Hide M, et al
    A case of chronic spontaneous urticaria with wheals lasting for more than a week.
    J Dermatol. 2025;52:344-347.
    >> Share

  69. HIDE M, Kishimoto M, Kotera I, Oh A, et al
    Analysis of disease burden in patients with hereditary angioedema from Japan by patient-reported outcomes.
    J Dermatol. 2025;52:256-269.
    >> Share

    January 2025
  70. SUGIYAMA A, Yano-Takamori A, Kojima K, Nishie H, et al
    Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events.
    J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17626.
    >> Share

  71. TRUPIANO N, Young K, Echuri H, Maghfour J, et al
    Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis.
    J Dermatol. 2025 Jan 15. doi: 10.1111/1346-8138.17622.
    >> Share

  72. CHIBA K, Shibata Y, Nobeyama Y, Ohko K, et al
    A case of allergic urticaria induced by green tea and matcha.
    J Dermatol. 2025 Jan 8. doi: 10.1111/1346-8138.17624.
    >> Share

    December 2024
  73. SAEKI H, Ohya Y, Arakawa H, Ichiyama S, et al
    English version of clinical practice guidelines for the management of atopic dermatitis 2024.
    J Dermatol. 2024 Dec 20. doi: 10.1111/1346-8138.17544.
    >> Share

  74. KAMADA H, Arakawa N, Kato M, Tanji T, et al
    Nemolizumab-induced exacerbation of atopic dermatitis.
    J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17589.
    >> Share

  75. IGARASHI A, Tsuji G, Murata R, Fukasawa S, et al
    A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis.
    J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17587.
    >> Share

    September 2024
  76. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
    Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials.
    J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17451.
    >> Share

  77. SATO T, Nakazono M, Ohyachi K, Okaniwa A, et al
    HPV 51-associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine.
    J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17454.
    >> Share

  78. KUZUMI A, Yoshizaki A, Matsuda K, Nagai K, et al
    Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome.
    J Dermatol. 2024;51:1240-1244.
    >> Share

  79. ENDO M, Yamamoto T
    Sarcoid reaction in lymph node metastasis of genital Paget disease.
    J Dermatol. 2024;51:e302-e303.
    >> Share

  80. KAMIGA M, Hayashi S, Ikegami T, Tokoro S, et al
    Hereditary angioedema with a normal C1 inhibitor in Japanese man.
    J Dermatol. 2024;51:e298-e299.
    >> Share

  81. MASUYUKI R, Sato E, Imafuku S
    A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody.
    J Dermatol. 2024;51:1252-1255.
    >> Share

    August 2024
  82. MATSUMOTO C, Kawakami Y, Ishibashi O, Sagara I, et al
    A clinical case of anaphylaxis after eating oatmeal contaminated with booklice (Liposcelis bostrychophila).
    J Dermatol. 2024 Aug 10. doi: 10.1111/1346-8138.17419.
    >> Share

    July 2024
  83. MINAMI Y, Kanzaki M, Egusa C, Ito T, et al
    A case of anaphylaxis after ingestion of Enokitake (Flammulina velutipes): Detection of the causative antigens.
    J Dermatol. 2024 Jul 12. doi: 10.1111/1346-8138.17383.
    >> Share

    June 2024
  84. HIOKI C, Oda Y, Moriwaki S, Fukunaga A, et al
    Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases.
    J Dermatol. 2024;51:873-877.
    >> Share

    May 2024
  85. YOSHIDA K, Numata T, Sugisaki R, Ito T, et al
    Orofacial granulomatosis associated with indium allergy and apical periodontitis.
    J Dermatol. 2024 May 31. doi: 10.1111/1346-8138.17286.
    >> Share

  86. TAIRA H, Ito Y, Yamamoto T, Koyama A, et al
    Elevated serum vasohibin-1 levels in atopic dermatitis: Implications for disease chronicity.
    J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17259.
    >> Share

    April 2024
  87. TANAKA A, Yuasa A, Kamei K, Nagano M, et al
    Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan.
    J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17234.
    >> Share

  88. FUJIOKA K, Kita M, Iwata M, Moriue T, et al
    Multiple cutaneous focal mucinosis in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17213.
    >> Share

  89. SUGIURA R, Hashimoto T, Okuno S, Satoh T, et al
    Expression of phosphorylated-Janus kinase 1 and IL-4Ralpha by dermal basophils and epidermal keratinocytes in atopic dermatitis-associated prurigo nodules: A case report.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17229.
    >> Share

  90. BABA A, Yamada K, Kanekura T
    Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17188.
    >> Share

  91. LIU Q, Su H, Hong C, Han J, et al
    Toxic epidermal necrolysis complicated with primary cutaneous aspergillosis: A report of four cases.
    J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17226.
    >> Share

  92. HANAMI Y, Yamamoto T
    Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
    J Dermatol. 2024 Apr 8. doi: 10.1111/1346-8138.17199.
    >> Share

  93. PAN X, Dong Z
    Yellow urticaria following plasma transfusion.
    J Dermatol. 2024;51:e108-e109.
    >> Share

  94. CHATPROEDPRAI S, Tiasiri N, Chantawarangkul K, Wananukul S, et al
    Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
    J Dermatol. 2024;51:509-517.
    >> Share

    March 2024
  95. HEMMI A, Okamura K, Nikaido M, Saito T, et al
    Post-COVID-19 vaccination diffuse cutaneous sarcoidosis.
    J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17194.
    >> Share

  96. UCHIYAMA A, Kosaka K, Ishikawa M, Inoue Y, et al
    Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.
    J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17173.
    >> Share

    February 2024
  97. HASHIZUME H, Ishikawa Y, Hata A
    Increased Demodex mites after dupilumab therapy in facial skin: A case report.
    J Dermatol. 2024 Feb 29. doi: 10.1111/1346-8138.17150.
    >> Share

  98. KOJIMA R, Miyake K, Shinohara R, Kushima M, et al
    Association between filaggrin gene mutations and the clinical features of molluscum contagiosum: The Yamanashi Adjunct Study of the Japan Environment and Children's Study.
    J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17157.
    >> Share

    December 2023
  99. NAKAIZUMI H, Kambe N, Irie H, Kaku Y, et al
    Neutrophilic epitheliotropism, proposed as an auto-inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases.
    J Dermatol. 2023 Dec 6. doi: 10.1111/1346-8138.17067.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016